SKI Market

A+| A| A-|

Indian Indices

Sensex

77,202.23 -642.29
( -0.83%)

Global Indices

Nasdaq

49,628.48 -303.12
(-0.61%)

Dow Jones

7,359.75 -26.37
(-0.36%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,288.99 -149.67
(-1.43%)

Forex

USD-INR

94.67 -0.51
(-0.53%)

EUR-INR

111.19 -0.10
(-0.09%)

GBP-INR

128.70 -0.19
(-0.14%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Bacil Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524516

INE711D01018

18.6255138

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

110.76

81.08

EPS(TTM)

Face Value()

Div & Yield %

0.51

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	0.00	0.00	0.00	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.66	0.13	0.11	0.06	0.07	0.14
Stock Adjustments	0.00	0.00	0.00	0.00	0.00	0.00
Total Income	0.66	0.13	0.11	0.06	0.07	0.14
EXPENDITURE :
Raw Materials	0.00	0.00	0.00	0.00	0.00	0.00
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	0.00
Employee Cost	0.14	0.10	0.09	0.06	0.05	0.09
Other Manufacturing Expenses	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Administrative Expenses	0.08	0.08	0.08	0.09	0.08	0.08
Miscellaneous Expenses	0.03	0.00	0.05	3.76	0.17	0.26
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	0.25	0.19	0.21	3.91	0.30	0.44
Operating Profit	0.41	-0.06	-0.10	-3.86	-0.23	-0.30
Interest	0.00	0.00	0.00	0.00	0.00	0.01
Gross Profit	0.41	-0.06	-0.10	-3.86	-0.23	-0.31
Depreciation	0.00	0.00	0.00	0.00	0.00	0.01
Profit Before Tax	0.41	-0.06	-0.10	-3.86	-0.23	-0.32
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Net Profit	0.40	-0.06	-0.10	-3.86	-0.24	-0.32
Extraordinary Items	0.53	0.10	0.05	-3.76	-0.14	-0.26
Adjusted Net Profit	-0.13	-0.16	-0.15	-0.10	-0.10	-0.06
Adjustment below Net Profit	16.37	0.17	-0.02	3.69	0.24	-0.21
P & L Balance brought forward	-5.31	-5.43	-5.30	-5.14	-5.14	-4.62
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	11.46	-5.31	-5.43	-5.30	-5.14	-5.14
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	0.29	-0.09	-0.16	-5.91	-0.37	-0.48
Earnings Per Share(Adj)-Unit Curr	0.29	-0.09	-0.16	-5.91	-0.37	-0.48
Book Value-Unit Curr	18.20	1.86	1.68	1.88	2.13	2.12
Book Value(Adj)-Unit Curr	18.20	1.86	1.68	1.88	2.13	2.12

77,202.23 -642.29 ( -0.83%)

49,628.48 -303.12 (-0.61%)

7,359.75 -26.37 (-0.36%)

62,681.30 -152.54 (-0.24%)

10,288.99 -149.67 (-1.43%)

94.67 -0.51 (-0.53%)

111.19 -0.10 (-0.09%)

128.70 -0.19 (-0.14%)

0.60 0.00 (0.12%)